National protocol for COVID-19 Vaccine AstraZeneca (ChAdOx1-S - recombinant), UK Health Security Agency (UKHSA) (Updated 29th October 2021)

This protocol is for the administration of COVID-19 Vaccine AstraZeneca (ChAdOx1-S [recombinant]) to individuals in accordance with the national COVID-19 vaccination programme. 29 October 2021Added version 5 – see page 3 for change history.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news